ATL Technology expands global footprint with acquisition of MedConx

ATL Technology, LLC, a top provider of electromechanical contract manufacturing of assemblies and devices with specialties in single use solutions, headquartered in Springville, Utah, has announced the acquisition of MedConx, Inc. (a California corporation with locations in Santa Clara, CA, and San Jose, Costa Rica).

This acquisition will incorporate MedConx's manufacturing facility in Costa Rica with ATL Technology's existing facility in Costa Rica, resulting in expanded operational capabilities and increased capacity. The facility is ISO 13485:2003 certified and joins ATL's existing facilities in China and the USA.

ATL's Costa Rican operations include distribution and engineering. The collocated MedConx facility adds manufacturing. "The MedConx acquisition allows us to provide an increased level of service by adding manufacturing to our current solutions for engineering and logistics in the region," says Brad Brown, CEO and founder of ATL Technology. "This combination creates a strong and balanced operation and is a tremendous benefit to the medical device industry in Costa Rica and North America."

Along with the geographic and operational advantages of this acquisition, customers will benefit from the inclusion of MedConx's proprietary Smart Technology™ into ATL's product and service offerings. Patented technology gained from the acquisition will foster ATL's ability to develop innovative solutions for its medical device customers. New additions to the ATL portfolio include the Smart Block™ connector family of products and mechanical use-limiting technology.

This acquisition capitalizes on the key strengths of both companies, according to Brown. He concludes, "Bringing MedConx into the ATL Technology family provides customers products and capabilities that complement each other with solid operational support behind them. It's a perfect fit."

Source:

ATL Technology, LLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Human midbrain organoids: A promising tool in the fight against Parkinson's disease